首页> 外文期刊>International Journal of Chronic Obstructive Pulmonary Disease >A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations
【24h】

A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations

机译:慢性阻塞性肺病严重程度的三个多维指标作为未来病情加重的预测指标的比较

获取原文
           

摘要

Background: Prediction of future exacerbations of chronic obstructive pulmonary disease (COPD) is a major concern for long-term management of this disease. Aim: To determine which of three multidimensional assessment systems (the body mass index, obstruction, dyspnea, and exercise capacity [BODE] index; dyspnea, obstruction, smoking, exacerbations [DOSE] index; or age, dyspnea, obstruction [ADO] index) is superior for predicting exacerbations. Methods: This was a 2-year prospective cohort study of COPD patients. Pulmonary function tests, the 6-minute walk distance (6MWD), Modified Medical Respiratory Council (MMRC) dyspnea scores, chest computed-tomography measurements, and body composition were analyzed, and predictions of exacerbation by the three assessment systems were compared. Results: Among 183 patients who completed the study, the mean annual exacerbation rate was 0.57 events per patient year, which correlated significantly with lower predicted forced expiratory volume in 1 second (FEV1) (P < 0.001), lower transfer coefficient of the lung for carbon monoxide (%DLco/VA) (P = 0.021), lesser 6MWD (P = 0.016), higher MMRC dyspnea score (P = 0.001), higher DOSE index (P < 0.001), higher BODE index (P = 0.001), higher ADO index (P = 0.001), and greater extent of emphysema (P = 0.002). For prediction of exacerbation, the areas under the curves were larger for the DOSE index than for the BODE and ADO indices (P < 0.001). Adjusted multiple logistic regression identified the DOSE index as a significant predictor of risk of COPD exacerbation. Conclusion: In this study, the DOSE index was a better predictor of exacerbations of COPD when compared with the BODE and ADO indices.
机译:背景:慢性阻塞性肺疾病(COPD)的未来加重的预测是对该疾病的长期管理的主要关注。目的:确定三个多维评估系统中的哪一个(体重指数,阻塞,呼吸困难和运动能力[BODE]指数;呼吸困难,阻塞,吸烟,急性发作[DOSE]指数;或年龄,呼吸困难,阻塞[ADO]指数)在预测病情恶化方面更胜一筹。方法:这是一项为期2年的COPD患者前瞻性队列研究。分析了肺功能测试,6分钟步行距离(6MWD),改良医学呼吸委员会(MMRC)呼吸困难评分,胸部计算机断层扫描测量值和身体成分,并比较了三种评估系统对病情加重的预测。结果:在完成研究的183位患者中,年平均加重率为每患者年0.57次事件,这与较低的1秒预计强制呼气量(FEV1)(P <0.001)和较低的肺转移系数显着相关。一氧化碳(%DLco / VA)(P = 0.021),小于6MWD(P = 0.016),较高的MMRC呼吸困难评分(P = 0.001),较高的DOSE指数(P <0.001),较高的BODE指数(P = 0.001),更高的ADO指数(P = 0.001)和更大程度的肺气肿(P = 0.002)。为了预测病情加重,曲线下的DOSE指数面积大于BODE和ADO指数(P <0.001)。调整后的多元逻辑回归将DOSE指数确定为COPD恶化风险的重要预测指标。结论:在这项研究中,与BODE和ADO指数相比,DOSE指数更好地预测了COPD恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号